Key result
Intraduodenal administration of acacetin prevented atrial fibrillation induction in anesthetized dogs at rates of 50% and 85.7%, without prolonging the QTc interval.
Why the study?
Does acacetin selectively inhibit atrial repolarization and prevent atrial fibrillation in preclinical models?
Does acacetin selectively inhibit atrial repolarization and prevent atrial fibrillation in preclinical models?
Acacetin is a promising atrium-selective agent that prevents atrial fibrillation induction in dogs without prolonging the QT interval.
Answers are grounded in this paper and cite their sources.
Acacetin shows AF prevention without QTc effects in dogs; extends preclinical data but leaves human translation open.
BACKGROUND: The development of atrium-selective antiarrhythmic agents is a current strategy for inhibiting atrial fibrillation (AF). The present study investigated whether the natural flavone acacetin from the traditional Chinese medicine Xuelianhua would be an atrium-selective anti-AF agent. METHODS AND RESULTS: The effects of acacetin on human atrial ultrarapid delayed rectifier K(+) current (I(Kur)) and other cardiac ionic currents were studied with a whole-cell patch technique. Acacetin suppressed I(Kur) and the transient outward K(+) current (IC(50) 3.2 and 9.2 mumol/L, respectively) and prolonged action potential duration in human atrial myocytes. The compound blocked the acetylcholine-activated K(+) current; however, it had no effect on the Na(+) current, L-type Ca(2+) current, or inward-rectifier K(+) current in guinea pig cardiac myocytes. Although acacetin caused a weak reduction in the hERG and hKCNQ1/hKCNE1 channels stably expressed in HEK 293 cells, it did not prolong the corrected QT interval in rabbit hearts. In anesthetized dogs, acacetin (5 mg/kg) prolonged the atrial effective refractory period in both the right and left atria 1 to 4 hours after intraduodenal administration without prolongation of the corrected QT interval, whereas sotalol at 5 mg/kg prolonged both the atrial effective refractory period and the corrected QT interval. Acacetin prevented AF induction at doses of 2.5 mg/kg (50%), 5 mg/kg (85.7%), and 10 mg/kg (85.7%). Sotalol 5 mg/kg also prevented AF induction (60%). CONCLUSIONS: The present study demonstrates that the natural compound acacetin is an atrium-selective agent that prolongs the atrial effective refractory period without prolonging the corrected QT interval and effectively prevents AF in anesthetized dogs after intraduodenal administration. These results indicate that oral acacetin is a promising atrium-selective agent for the treatment of AF.
No takes yet. Share an insight, caveat, or question.
Li et al. (2008) studied Atrial fibrillation. Acacetin vs. Sotalol 5 mg/kg was evaluated on Prevention of AF induction. Intraduodenal administration of acacetin prevented atrial fibrillation induction in anesthetized dogs at rates of 50% and 85.7%, without prolonging the QTc interval.
Synapse has enriched 10 related papers. Consider them for comparative context: